TrialThe Lancet. Haematology2017

Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trial.

Sarah A Holstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.